From 1st April 2026, the eligibility criteria for the Respiratory Syncytial Virus (RSV) programme will change to allow people aged 80 years and over, and all residents in Care Homes for older adults, to receive the RSV vaccine on the NHS. This means all adults aged 75 years and over who have not previously received a single dose of RSV vaccine under the NHS RSV campaign will be eligible for the vaccine from this point forward. In addition, all residents in Care Homes for older adults will also become eligible, regardless of their age, due to their increased risk from RSV.
The vaccine used in the programme will continue to be Abrysvo® on a one-dose schedule.